Cargando…

Introducing an Artificial Deazaflavin Cofactor in Escherichia coli and Saccharomyces cerevisiae

[Image: see text] Deazaflavin-dependent whole-cell conversions in well-studied and industrially relevant microorganisms such as Escherichia coli and Saccharomyces cerevisiae have high potential for the biocatalytic production of valuable compounds. The artificial deazaflavin FOP (FO-5′-phosphate) ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Misun, Drenth, Jeroen, Trajkovic, Milos, de Jong, René M., Fraaije, Marco W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859854/
https://www.ncbi.nlm.nih.gov/pubmed/35044755
http://dx.doi.org/10.1021/acssynbio.1c00552
_version_ 1784654546722619392
author Lee, Misun
Drenth, Jeroen
Trajkovic, Milos
de Jong, René M.
Fraaije, Marco W.
author_facet Lee, Misun
Drenth, Jeroen
Trajkovic, Milos
de Jong, René M.
Fraaije, Marco W.
author_sort Lee, Misun
collection PubMed
description [Image: see text] Deazaflavin-dependent whole-cell conversions in well-studied and industrially relevant microorganisms such as Escherichia coli and Saccharomyces cerevisiae have high potential for the biocatalytic production of valuable compounds. The artificial deazaflavin FOP (FO-5′-phosphate) can functionally substitute the natural deazaflavin F(420) and can be synthesized in fewer steps, offering a solution to the limited availability of the latter due to its complex (bio)synthesis. Herein we set out to produce FOP in vivo as a scalable FOP production method and as a means for FOP-mediated whole-cell conversions. Heterologous expression of the riboflavin kinase from Schizosaccharomyces pombe enabled in vivo phosphorylation of FO, which was supplied by either organic synthesis ex vivo, or by a coexpressed FO synthase in vivo, producing FOP in E. coli as well as in S. cerevisiae. Through combined approaches of enzyme engineering as well as optimization of expression systems and growth media, we further improved the in vivo FOP production in both organisms. The improved FOP production yield in E. coli is comparable to the F(420) yield of native F(420)-producing organisms such as Mycobacterium smegmatis, but the former can be achieved in a significantly shorter time frame. Our E. coli expression system has an estimated production rate of 0.078 μmol L(–1) h(–1) and results in an intracellular FOP concentration of about 40 μM, which is high enough to support catalysis. In fact, we demonstrate the successful FOP-mediated whole-cell conversion of ketoisophorone using E. coli cells. In S. cerevisiae, in vivo FOP production by SpRFK using supplied FO was improved through media optimization and enzyme engineering. Through structure-guided enzyme engineering, a SpRFK variant with 7-fold increased catalytic efficiency compared to the wild type was discovered. By using this variant in optimized media conditions, FOP production yield in S. cerevisiae was 20-fold increased compared to the very low initial yield of 0.24 ± 0.04 nmol per g dry biomass. The results show that bacterial and eukaryotic hosts can be engineered to produce the functional deazaflavin cofactor mimic FOP.
format Online
Article
Text
id pubmed-8859854
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-88598542022-02-22 Introducing an Artificial Deazaflavin Cofactor in Escherichia coli and Saccharomyces cerevisiae Lee, Misun Drenth, Jeroen Trajkovic, Milos de Jong, René M. Fraaije, Marco W. ACS Synth Biol [Image: see text] Deazaflavin-dependent whole-cell conversions in well-studied and industrially relevant microorganisms such as Escherichia coli and Saccharomyces cerevisiae have high potential for the biocatalytic production of valuable compounds. The artificial deazaflavin FOP (FO-5′-phosphate) can functionally substitute the natural deazaflavin F(420) and can be synthesized in fewer steps, offering a solution to the limited availability of the latter due to its complex (bio)synthesis. Herein we set out to produce FOP in vivo as a scalable FOP production method and as a means for FOP-mediated whole-cell conversions. Heterologous expression of the riboflavin kinase from Schizosaccharomyces pombe enabled in vivo phosphorylation of FO, which was supplied by either organic synthesis ex vivo, or by a coexpressed FO synthase in vivo, producing FOP in E. coli as well as in S. cerevisiae. Through combined approaches of enzyme engineering as well as optimization of expression systems and growth media, we further improved the in vivo FOP production in both organisms. The improved FOP production yield in E. coli is comparable to the F(420) yield of native F(420)-producing organisms such as Mycobacterium smegmatis, but the former can be achieved in a significantly shorter time frame. Our E. coli expression system has an estimated production rate of 0.078 μmol L(–1) h(–1) and results in an intracellular FOP concentration of about 40 μM, which is high enough to support catalysis. In fact, we demonstrate the successful FOP-mediated whole-cell conversion of ketoisophorone using E. coli cells. In S. cerevisiae, in vivo FOP production by SpRFK using supplied FO was improved through media optimization and enzyme engineering. Through structure-guided enzyme engineering, a SpRFK variant with 7-fold increased catalytic efficiency compared to the wild type was discovered. By using this variant in optimized media conditions, FOP production yield in S. cerevisiae was 20-fold increased compared to the very low initial yield of 0.24 ± 0.04 nmol per g dry biomass. The results show that bacterial and eukaryotic hosts can be engineered to produce the functional deazaflavin cofactor mimic FOP. American Chemical Society 2022-01-19 2022-02-18 /pmc/articles/PMC8859854/ /pubmed/35044755 http://dx.doi.org/10.1021/acssynbio.1c00552 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Lee, Misun
Drenth, Jeroen
Trajkovic, Milos
de Jong, René M.
Fraaije, Marco W.
Introducing an Artificial Deazaflavin Cofactor in Escherichia coli and Saccharomyces cerevisiae
title Introducing an Artificial Deazaflavin Cofactor in Escherichia coli and Saccharomyces cerevisiae
title_full Introducing an Artificial Deazaflavin Cofactor in Escherichia coli and Saccharomyces cerevisiae
title_fullStr Introducing an Artificial Deazaflavin Cofactor in Escherichia coli and Saccharomyces cerevisiae
title_full_unstemmed Introducing an Artificial Deazaflavin Cofactor in Escherichia coli and Saccharomyces cerevisiae
title_short Introducing an Artificial Deazaflavin Cofactor in Escherichia coli and Saccharomyces cerevisiae
title_sort introducing an artificial deazaflavin cofactor in escherichia coli and saccharomyces cerevisiae
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859854/
https://www.ncbi.nlm.nih.gov/pubmed/35044755
http://dx.doi.org/10.1021/acssynbio.1c00552
work_keys_str_mv AT leemisun introducinganartificialdeazaflavincofactorinescherichiacoliandsaccharomycescerevisiae
AT drenthjeroen introducinganartificialdeazaflavincofactorinescherichiacoliandsaccharomycescerevisiae
AT trajkovicmilos introducinganartificialdeazaflavincofactorinescherichiacoliandsaccharomycescerevisiae
AT dejongrenem introducinganartificialdeazaflavincofactorinescherichiacoliandsaccharomycescerevisiae
AT fraaijemarcow introducinganartificialdeazaflavincofactorinescherichiacoliandsaccharomycescerevisiae